Psilocybin mushrooms, commonly referred to as “shrooms,” have garnered significant attention for their potential therapeutic benefits, particularly in treating depression and anxiety. However, individuals currently taking antidepressants, such as Zoloft, Prozac, Cymbalta, Wellbutrin, and Effexor, often wonder if it is safe to combine psilocybin with their prescribed medications. The interaction between psilocybin and antidepressants like SSRIs, SNRIs, or NDRIs raises several critical questions: Does psilocybin work effectively while on antidepressants? Does it increase the risk of serotonin syndrome? Can you take shrooms on Zoloft, Prozac, or Wellbutrin without experiencing side effects?
This comprehensive guide provides scientifically backed insights into how psilocybin interacts with antidepressants, the potential risks involved, and how some individuals have approached microdosing and tapering off medication before using psychedelics. Additionally, we will delve into what a zip of shrooms is, its measurement, potency, and storage considerations, ensuring a complete understanding of psilocybin use from both a therapeutic and practical perspective.
A zip is a colloquial term for one ounce (28 grams) of dried psilocybin mushrooms. This unit of measurement is commonly used in discussions about dosing, purchasing, or storing psilocybin mushrooms.
The price of a zip varies significantly based on several factors:
Psilocybin, the psychoactive compound in magic mushrooms, primarily affects the 5-HT2A serotonin receptors in the brain. By stimulating these receptors, psilocybin induces altered perception, mood elevation, and even mystical experiences. However, its interaction with SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), and NDRIs (Norepinephrine-Dopamine Reuptake Inhibitors) can significantly alter the psychedelic experience.
SSRIs, such as Prozac (fluoxetine), Zoloft (sertraline), and Lexapro (escitalopram), are known to blunt the effects of psilocybin. Since these medications work by increasing serotonin levels in the brain, psilocybin’s impact can be diminished or altered, leading to a less intense experience. People taking Effexor (venlafaxine), Cymbalta (duloxetine), or other SNRIs may experience stronger emotional responses, increased heart rate, or heightened anxiety.
Meanwhile, Wellbutrin (bupropion), an NDRI, does not directly affect serotonin but is associated with an increased risk of seizures, which can make combining it with psilocybin particularly dangerous. This risk underscores the importance of caution when considering the use of psilocybin alongside any antidepressant.
There is no universal answer, as the interaction between psilocybin and antidepressants varies depending on the medication and the individual. Many people have reported reduced psychedelic effects when taking psilocybin on SSRIs like Prozac or Zoloft. Others experience unpredictable mood shifts, increased anxiety, or dissociation.
Some individuals choose to microdose psilocybin while on antidepressants to test their body’s response. Microdosing involves taking sub-perceptual doses of psilocybin a few times a week. This approach has been widely discussed in the psychedelic community as a way to gain mild cognitive and emotional benefits without full psychedelic effects. However, combining psilocybin and SSRIs, SNRIs, or Wellbutrin should always be approached with caution and ideally under the supervision of a medical professional.
Asana Recovery works with most PPO plans, covering up to 100%. See if your insurance can help fund your journey. Click below to get a free quote.
One of the biggest risks of combining psilocybin and antidepressants is serotonin syndrome, a condition caused by excessive serotonin levels in the brain. Symptoms can include:
Though rare, serotonin syndrome is more likely when higher doses of psilocybin are taken while on SSRIs or SNRIs It is crucial to be aware of these symptoms and seek medical attention immediately if they occur.
If considering tapering, it’s critical to consult a medical professional and follow a gradual reduction plan. Tapering off antidepressants can help minimize withdrawal symptoms and ensure a safer transition to using psilocybin. However, this process should be carefully managed to avoid any adverse effects.
While some people report benefits from using psilocybin alongside antidepressants, others experience blunted effects, anxiety, or even increased risks like serotonin syndrome. Microdosing may be a safer alternative for those who choose to explore psilocybin while still on medication, but macrodosing is unpredictable and should be approached with caution.
It is essential to consult with a healthcare professional before making any decisions regarding the use of psilocybin with antidepressants.
At Asana Recovery, we understand the complexities and risks associated with substances like psilocybin mushrooms. Whether you’re exploring their effects, dealing with potential misuse, or seeking a path to recovery, our compassionate team is here to help. We offer personalized treatment plans and a supportive environment to address your unique needs. Contact Asana Recovery today to learn how we can guide you toward a healthier, balanced life free from substance-related challenges. Your journey to recovery starts here.
We get it. Addiction recovery is tough. That’s why our programs are founded and staffed by people in recovery – people who truly understand.
Psilocybin’s effects may be blunted when taken with Zoloft (sertraline), as SSRIs alter serotonin receptor activity. While some users report mild experiences, others notice little to no effect. There is also a small risk of serotonin syndrome when combining the two.
Prozac (fluoxetine) is an SSRI that may reduce the intensity of a psilocybin trip. Higher doses of shrooms may be needed to achieve the desired effects, but increasing dosage can pose risks.
Combining Wellbutrin (bupropion) and psilocybin is not recommended due to an increased risk of seizures. Wellbutrin does not act on serotonin but can heighten stimulation, leading to greater anxiety or discomfort during a psychedelic trip.
Effexor (venlafaxine) is an SNRI that can cause strong emotional responses, increased heart rate, and anxiety when combined with psilocybin. Some users report intensified experiences, while others experience numbed psychedelic effects.
Psilocybin does not cancel out SSRIs, but its effects are often diminished in individuals taking Zoloft, Prozac, Lexapro, and other SSRIs. This is because SSRIs downregulate serotonin receptors, which psilocybin relies on for its psychedelic effects.
While rare, serotonin syndrome is possible when psilocybin is taken alongside SSRIs (such as Zoloft or Prozac) or SNRIs (such as Cymbalta or Effexor). Symptoms include confusion, agitation, muscle spasms, fever, and increased heart rate.
Some individuals microdose psilocybin while taking antidepressants to experience subtle cognitive benefits without full psychedelic effects. However, results vary widely, and professional guidance is recommended.
Take your first step towards lasting recovery. At Asana, we offer effective, insurance-covered treatment for addiction and mental health, guided by experts who understand because they’ve been there. Start your healing today.
This book has helped so many men and women; and we want to give it you for FREE. Get signed up today and discover how to unlock the grip of addiction and get back to living your best life.
In this book, you’ll discover…
— The Most Common Misconceptions About Addiction and Rehab
— Why Rock Bottom is a Myth and What You Can Do About It
–The Steps to Healing From Trauma, Both Mentally and Emotionally
–And much more!
Asana Recovery is licensed and certified by the State Department of Health Care Services.
© Copyright 2024 Asana Recovery™ | All Rights Reserved | Privacy Policy
You could save up to 100% of your treatment using your Insurance.
Asana Recovery
We firmly believe that the internet should be available and accessible to anyone, and are committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability.
To fulfill this, we aim to adhere as strictly as possible to the World Wide Web Consortium’s (W3C) Web Content Accessibility Guidelines 2.1 (WCAG 2.1) at the AA level. These guidelines explain how to make web content accessible to people with a wide array of disabilities. Complying with those guidelines helps us ensure that the website is accessible to all people: blind people, people with motor impairments, visual impairment, cognitive disabilities, and more.
This website utilizes various technologies that are meant to make it as accessible as possible at all times. We utilize an accessibility interface that allows persons with specific disabilities to adjust the website’s UI (user interface) and design it to their personal needs.
Additionally, the website utilizes an AI-based application that runs in the background and optimizes its accessibility level constantly. This application remediates the website’s HTML, adapts Its functionality and behavior for screen-readers used by the blind users, and for keyboard functions used by individuals with motor impairments.
If you’ve found a malfunction or have ideas for improvement, we’ll be happy to hear from you. You can reach out to the website’s operators by using the following email
Our website implements the ARIA attributes (Accessible Rich Internet Applications) technique, alongside various different behavioral changes, to ensure blind users visiting with screen-readers are able to read, comprehend, and enjoy the website’s functions. As soon as a user with a screen-reader enters your site, they immediately receive a prompt to enter the Screen-Reader Profile so they can browse and operate your site effectively. Here’s how our website covers some of the most important screen-reader requirements, alongside console screenshots of code examples:
Screen-reader optimization: we run a background process that learns the website’s components from top to bottom, to ensure ongoing compliance even when updating the website. In this process, we provide screen-readers with meaningful data using the ARIA set of attributes. For example, we provide accurate form labels; descriptions for actionable icons (social media icons, search icons, cart icons, etc.); validation guidance for form inputs; element roles such as buttons, menus, modal dialogues (popups), and others. Additionally, the background process scans all the website’s images and provides an accurate and meaningful image-object-recognition-based description as an ALT (alternate text) tag for images that are not described. It will also extract texts that are embedded within the image, using an OCR (optical character recognition) technology. To turn on screen-reader adjustments at any time, users need only to press the Alt+1 keyboard combination. Screen-reader users also get automatic announcements to turn the Screen-reader mode on as soon as they enter the website.
These adjustments are compatible with all popular screen readers, including JAWS and NVDA.
Keyboard navigation optimization: The background process also adjusts the website’s HTML, and adds various behaviors using JavaScript code to make the website operable by the keyboard. This includes the ability to navigate the website using the Tab and Shift+Tab keys, operate dropdowns with the arrow keys, close them with Esc, trigger buttons and links using the Enter key, navigate between radio and checkbox elements using the arrow keys, and fill them in with the Spacebar or Enter key.Additionally, keyboard users will find quick-navigation and content-skip menus, available at any time by clicking Alt+1, or as the first elements of the site while navigating with the keyboard. The background process also handles triggered popups by moving the keyboard focus towards them as soon as they appear, and not allow the focus drift outside it.
Users can also use shortcuts such as “M” (menus), “H” (headings), “F” (forms), “B” (buttons), and “G” (graphics) to jump to specific elements.
We aim to support the widest array of browsers and assistive technologies as possible, so our users can choose the best fitting tools for them, with as few limitations as possible. Therefore, we have worked very hard to be able to support all major systems that comprise over 95% of the user market share including Google Chrome, Mozilla Firefox, Apple Safari, Opera and Microsoft Edge, JAWS and NVDA (screen readers).
Despite our very best efforts to allow anybody to adjust the website to their needs. There may still be pages or sections that are not fully accessible, are in the process of becoming accessible, or are lacking an adequate technological solution to make them accessible. Still, we are continually improving our accessibility, adding, updating and improving its options and features, and developing and adopting new technologies. All this is meant to reach the optimal level of accessibility, following technological advancements. For any assistance, please reach out to